Curated News
By: NewsRamp Editorial Staff
April 04, 2024
Classiq and Quantum Intelligence Corp. (QIC) Partner on Quantum-Accelerated Drug Development
Discuss on Reddit
Discuss on SubstackTLDR
- Accelerate drug development by applying quantum computing to pharmacology, gaining an edge in predicting potential side effects and interactions.
- Classiq and Quantum Intelligence Corp. partner to explore quantum computing in pharmacology, focusing on predictive and analytical applications, drug design, and side effect prediction.
- The collaboration aims to reduce risks in drug development and clinical trials, improving efficacy and safety of drug candidates, ultimately leading to better healthcare outcomes.
- Classiq and Quantum Intelligence Corp. use quantum computing to revolutionize drug discovery, predicting compound properties and enhancing drug safety and efficacy.
Impact - Why it Matters
The partnership between Classiq and Quantum Intelligence Corp. (QIC) is significant because it represents a new era of accelerated drug development using quantum computing technology. This collaboration has the potential to revolutionize the drug development process, leading to improved drug safety and efficacy while reducing development costs and timelines. By harnessing the power of quantum computing in pharmacology, this partnership could have a profound impact on the future of healthcare and pharmaceutical innovation.
Summary
Classiq and Quantum Intelligence Corp. (QIC), Korea, have partnered to accelerate drug development using quantum computing in pharmacology. The collaboration aims to enhance the efficiency and accuracy of drug development by integrating Classiq's quantum computing platform with QIC's drug development platform. This partnership will explore the use of quantum computing in pharmacology for predictive and analytical applications, including the discovery and design of novel drug candidates and the prediction of potential side effects and interactions.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Classiq and Quantum Intelligence Corp. (QIC) Partner on Quantum-Accelerated Drug Development
